Literature DB >> 17898928

Atypical cytostatic mechanism of N-1-sulfonylcytosine derivatives determined by in vitro screening and computational analysis.

Fran Supek1, Marijeta Kralj, Marko Marjanović, Lidija Suman, Tomislav Smuc, Irena Krizmanić, Biserka Zinić.   

Abstract

We have previously shown that N-1-sulfonylpyrimidine derivatives have strong antiproliferative activity on human tumor cell lines, whereby 1-(p-toluenesulfonyl)cytosine showed good selectivity with regard to normal cells and was easily synthesized on a large scale. In the present work we have used an interdisciplinary approach to elucidate the compounds' mechanistic class. An augmented number of cell lines (11) has allowed a computational search for compounds with similar activity profiles and/or mechanistic class by integrating our data with the comprehensive DTP-NCI database. We applied supervised machine learning methodology (Random Forest classifier), which offers information complementary to unsupervised algorithms commonly used for analysis of cytostatic activity profiles, such as self-organizing maps. The computational results taken together with cell cycle perturbation and apoptosis analysis of the cell lines point to an unusual mechanism of cytostatic action, possibly a combination of nucleic acid antimetabolite activity and a novel molecular mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898928     DOI: 10.1007/s10637-007-9084-1

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  22 in total

1.  Functional genomics of UV radiation responses in human cells.

Authors:  Christine A Koch-Paiz; Sally A Amundson; Michael L Bittner; Paul S Meltzer; Albert J Fornace
Journal:  Mutat Res       Date:  2004-05-18       Impact factor: 2.433

2.  Evaluation of different biological data and computational classification methods for use in protein interaction prediction.

Authors:  Yanjun Qi; Ziv Bar-Joseph; Judith Klein-Seetharaman
Journal:  Proteins       Date:  2006-05-15

3.  Routine determination of sulfonylurea, imidazolinone, and sulfonamide herbicides at nanogram-per-liter concentrations by solid-phase extraction and liquid chromatography/mass spectrometry.

Authors:  E T Furlong; M R Burkhardt; P M Gates; S L Werner; W A Battaglin
Journal:  Sci Total Environ       Date:  2000-04-05       Impact factor: 7.963

Review 4.  Oral antidiabetic drugs: an overview.

Authors:  A Melander
Journal:  Diabet Med       Date:  1996-09       Impact factor: 4.359

5.  Antineoplastic activity of novel N-1-sulfonypyrimidine derivatives.

Authors:  L Glavas-Obrovac; I Karner; B Zinic; K Pavelic
Journal:  Anticancer Res       Date:  2001 May-Jun       Impact factor: 2.480

6.  Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.

Authors:  D J Morré; L Y Wu; D M Morré
Journal:  Biochim Biophys Acta       Date:  1998-03-02

Review 7.  5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.

Authors:  J L Grem
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

8.  Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives.

Authors:  Juan Antonio Marchal; Houria Boulaiz; Inés Suárez; Estrella Saniger; Joaquín Campos; Esmeralda Carrillo; José Prados; Miguel Angel Gallo; Antonio Espinosa; Antonia Aránega
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

9.  Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts.

Authors:  R M Schultz; R L Merriman; J E Toth; J E Zimmermann; L W Hertel; S L Andis; D E Dudley; P G Rutherford; L R Tanzer; G B Grindey
Journal:  Oncol Res       Date:  1993       Impact factor: 5.574

10.  Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.

Authors:  P J Houghton; J Sosinski; J H Thakar; G B Boder; G B Grindey
Journal:  Biochem Pharmacol       Date:  1995-03-01       Impact factor: 5.858

View more
  4 in total

1.  Putative mechanisms of antitumor activity of cyano-substituted heteroaryles in HeLa cells.

Authors:  Katja Ester; Fran Supek; Kristina Majsec; Marko Marjanović; David Lembo; Manuela Donalisio; Tomislav Šmuc; Ivana Jarak; Grace Karminski-Zamola; Marijeta Kralj
Journal:  Invest New Drugs       Date:  2010-11-03       Impact factor: 3.850

2.  In vivo toxicity study of N-1-sulfonylcytosine derivatives and their mechanisms of action in cervical carcinoma cell line.

Authors:  Jelena Kašnar-Šamprec; Ivana Ratkaj; Katarina Mišković; Marina Pavlak; Mirela Baus-Lončar; Sandra Kraljević Pavelić; Ljubica Glavaš-Obrovac; Biserka Žinić
Journal:  Invest New Drugs       Date:  2011-03-22       Impact factor: 3.850

3.  Mass spectrometry and theoretical studies on N-C bond cleavages in the N-sulfonylamidino thymine derivatives.

Authors:  Renata Kobetić; Snježana Kazazić; Borislav Kovačević; Zoran Glasovac; Luka Krstulović; Miroslav Bajić; Biserka Žinić
Journal:  J Am Soc Mass Spectrom       Date:  2015-03-12       Impact factor: 3.109

4.  Adenovirally mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment.

Authors:  Sandra Kraljević Pavelić; Marko Marjanović; Miroslav Poznić; Marijeta Kralj
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-23       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.